☎ Enquire Now

1,364 Anti-Cancer Medicines Get New Prices in India: NPPA Update 2026

1,364 Anti-Cancer Medicines Get New Prices in India: NPPA Update 2026

The revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer medicine formulations came into effect across India on November 9, 2026. This initiative aims to make essential cancer medicines more affordable and reduce the financial burden on patients undergoing cancer treatment.The National Pharmaceutical Pricing Authority (NPPA), functioning under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, implemented the revised prices through its Trade Margin Rationalisation (TMR) mechanism. This mechanism helps regulate trade margins in the pharmaceutical supply chain and supports the availability of medicines at more reasonable prices.

APPSC Group 2 Notification 2026

APPSC Group 2 Notification 2026

According to the reported estimates, the revised prices are expected to generate annual savings of approximately ₹3,540.38 crore for consumers. The decision is expected to provide financial relief to cancer patients and their families by reducing expenditure on essential medicines.The initiative reflects the Government of India’s efforts to improve access to affordable healthcare and strengthen the country’s pharmaceutical pricing framework. The NPPA plays an important role in monitoring medicine prices and ensuring the availability of essential medicines at regulated rates.For competitive examination aspirants, this development is important under Health Current Affairs, Indian Economy, Government Initiatives and Pharmaceutical Price Regulation.

NDA Coaching in Patna Bihar for Girls: Eligibility & Tips